TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. (Q54571377)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. |
scientific article |
Statements
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. (English)
1 reference
Karin G Hermans
1 reference
Ronald van Marion
1 reference
Herman van Dekken
1 reference
Guido Jenster
1 reference
Wytske M van Weerden
1 reference
Jan Trapman
1 reference
1 November 2006
1 reference
66
1 reference
22
1 reference
10658-10663
1 reference
Identifiers
1 reference